sprycel dasatinib 20 mg tablet bottle
bristol-myers squibb australia pty ltd - dasatinib, quantity: 20 mg - tablet, film coated - excipient ingredients: hyprolose; microcrystalline cellulose; magnesium stearate; croscarmellose sodium; lactose monohydrate; titanium dioxide; hypromellose; macrogol 400 - sprycel is indicated for the treatment of adults aged 18 years or over with: - newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. - chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukameia with resistance or intolerance to prior therapy including imatinib. - newly diagnosed philadelphia chromosome positive acute lymphoblastic leukameia integrated with chemotherapy. - philadelphia chromosome positive acute lymphoblastic leukamia with resistance or intolerance to prior therapy.,sprycel is indicated for the treatment of paediatric patients with: - ph+ cml in the chronic phase. - newly diagnosed ph+ all in combination with chemotherapy.
tenofovir disoproxil/emtricitabine/efavirenz viatris 300/200/600 tenofovir disoproxil maleate 300mg/emtricitabine 200mg/efavirenz 600mg tablet bottle
alphapharm pty ltd - emtricitabine, quantity: 200 mg; efavirenz, quantity: 600 mg; tenofovir disoproxil maleate, quantity: 300 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium metabisulfite; hyprolose; colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; ferric oxide; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - tenofovir disoproxil/ emtricitabine/ efavirenz mylan 300/200/600 is indicated for the treatment of hiv infected adults over the age of 18 years.,this indication is based on analyses of plasma hiv-1 rna levels and cd4 cell counts in controlled studies of viread, emtriva and stocrin in treatment-na?ve and treatment experienced adults.
klacid xl 500mg modified-release tablets
abbott laboratories limited - clarithromycin 500 mg - modified-release tablet
klacid forte 500mg coated tablets
neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - clarithromycin - film-coated tablet - clarithromycin 500 mg - antibacterials for systemic use
klacid 500 tablet, film-coated 500 mg
abbott laboratories s.a (pty) ltd., south africa - clarithromycin - tablet, film-coated - 500 mg
klacid forte
abbott laboratories ireland ltd - clarithromycin - film coated tablet - 500 milligram
klacid forte
g & a licensing limited - clarithromycin - film coated tablet - 500 milligram
klacid tablet 250 mg
abbott laboratories (singapore ) private limited - clarithromycin - tablet, film coated - 250 mg - clarithromycin 250 mg
klacid 250mg film-coated tablets
neofarma pharmaceuticals limited 42-46, mill street, qormi, qrm 3105, malta - clarithromycin - film-coated tablet - clarithromycin 250 mg - antibacterials for systemic use
klacid 250 mg film-coated tablets
nm pharma limited 3/4, cantrija complex triq it-targa, il-maghtab naxxar nxr 6613 , malta - clarithromycin - film-coated tablet - clarithromycin 250 mg - antibacterials for systemic use